ArticleActa pharmacologica Sinica2017

Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitors.

Zhong-Min Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.